San Francisco, 11 December 2018: According to a report
by Grand View Research, Inc., global proteomics market is anticipated to value USD 24.8 billion by 2024. Growing
requirement for better and timely diagnosis of fatal diseases such as diabetes
and cancer is anticipated to propel demand for proteomics. It can provide
essential information related to broad range of diseases and support diagnosis
for better treatment.
Rising cases of chronic
diseases such as diabetes, cardiovascular disorders, and cancer owing to
unhealthy lifestyle and sudden climatic changes can augment market growth.
Favorable regulations and government policies are expected to research and
development in proteomics. This, in turn can augment growth of market over next
few years. Continual technological advancements in the field such as multiple
reaction monitoring, which can quantify proteins in cerebrospinal fluid for
detection of later stages of multiple sclerosis can augment demand for
proteomics. This, in turn can stimulate growth of market during the forecast
period (2013 to 2024).
The proteomics market can be
segregated on the basis of product, technology, application, and region. Based
on product, the market can be categorized into instruments, reagents, and
services. In 2015, regents segment dominated the market and accounted for fast
growth attributed to wide spread research in academic institutes. In addition,
high frequency usage of kits, chemicals, reagent, and strips for various
analysis of various biological samples can fuel growth. The segment is expected
to witness substantial growth at CAGR of 8.5% during the forecast period.
Access
Research Report of Proteomics
Market@ www.grandviewresearch.com/industry-analysis/proteomics-market
Similarly, introduction of
technologically advanced instruments such as 2D electrophoresis protein
analyzers can augment growth of market. In addition, instruments such as
electrophoresis instruments and biochip analyzers can be used for
quantification of proteins. Moreover, rising demand for fast, user-friendly,
cost-effective, and accurate devices can fuel growth of segment.
Based on technology, the
market can be classified into microarray instruments, x-ray crystallography,
spectroscopy, chromatography, protein fractionation systems, electrophoresis,
and surface plasma resonance systems. Large scale analysis of proteins through
techniques such as x-ray crystallography, protein fractionation systems,
microarray, and surface plasma resonance can provide view of molecular and
cellular functions that can give access to overall information of complex
processes in living systems. Moreover, increasing importance of such studies
for targeted diagnosis and treatment can leads to rise in demand for proteomics
during the forecast period.
In 2015, microarray segment
dominated the market and accounted for revenue equivalent to USD 5.6 billion.
Ability of microarrays to produce more information from small samples can fuel
market growth. They can give advantage of label-free detection, direct, and
absolute quantification, and full imprint of proteins.
Moreover, spectroscopy segment
is predicted to grow fast over the forecast period. Introduction of novel
technologies coupled with rising demand for accurate and rapid devices can fuel
analysis of proteins. This, in turn can fuel growth of segment.
Browse more reports of this category by
Grand View Research at: www.grandviewresearch.com/industry/biotechnology
Based on application, the
market can be clinical diagnosis, drug discovery, and others. Clinical
diagnosis are expected to foresee significant growth attributed to wide range
of application that can include host-pathogen interaction, disease biomarker
discovery, personalized medicines, study of disease pathogenesis, and
identification of drug target. In addition, introduction of technologically
advanced instruments, increasing awareness on newer diagnostic techniques, and
growing use of personalized medicines can fuel market growth.
Regional segmentation includes
Europe, North America, Asia Pacific, Latin America, and Middle East &
Africa (MEA). In 2015, North America dominated the market and accounted for 40%
market share. Prevalence of superior healthcare infrastructure, large base of
target population, and presence of key market players in the region can fuel
market growth. In addition, sufficient funding from local governments for
R&D can foster growth of market in the region.
In Asia Pacific, the market is
predicted to witness significant growth at CAGR of 12%. Developing countries
such as India and China are expected to have higher chances of growth during
the forecast period. In addition, increasing funding from government and
private organizations for research and growth in proteomics based outsourcing
to the region can augment growth of market.
Some of the leading companies
offering proteomics are Bio-Rad Laboratories; Thermo Fisher Scientific, Inc.;
Roche Diagnostics; Illumina, Inc.; and GE Healthcare. Most companies are
expected to be involved in R&D activities for development of
instrument-compatible kits. This is expected to be their major strategic
initiative to sustain market position.
Access
Press Release of Proteomics Market@ www.grandviewresearch.com/press-release/global-proteomics-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and fact-based
research across a range of industries, from technology to chemicals, materials
and healthcare.
No comments:
Post a Comment